Abstract
Dr. Beaulieu: We asked the panelists to spend about ten minutes each, addressing two questions. The first question is which in vitro and in vivo models or methods should be considered to evaluate the public health risk associated with antimicrobial residues in food, and can the model or method be used to evaluate more than one microbiological or functional endpoint in one test? The second question is how should the results obtained be used to establish an ADI? Is the standard toxicology formula appropriate to calculate an ADI for antimicrobial residues?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
